financetom
Business
financetom
/
Business
/
Disney acquires rights to 'Impossible Creatures' book series for film franchise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Disney acquires rights to 'Impossible Creatures' book series for film franchise
Oct 7, 2025 10:33 AM

Oct 7 (Reuters) - Disney ( DIS ) said on Tuesday it has

secured theatrical film and ancillary rights to British writer

Katherine Rundell's fantasy book series, "Impossible Creatures,"

with plans to adapt the first two books for the big screen.

The series is set in the fictional world of the Glimouria

Archipelago, a "richly imagined universe brimming with unique

characters", Disney ( DIS ) said, which it expects to "captivate

audiences for years to come."

"Impossible Creatures," which initially debuted as a planned

trilogy, was expanded to a five-book series earlier this year

through two major seven-figure publishing deals with Bloomsbury

and Knopf.

The second and the latest installment, "The Poisoned King,"

became a global bestseller and made Rundell the first U.K.

children's author since J.K. Rowling to simultaneously reach No.

1 on the children's book charts in both the U.K. and the U.S.,

Disney ( DIS ) said.

As part of the deal, Rundell will adapt the first two books

into feature film screenplays under the Disney Live Action

banner, and will produce the films with creative partner Charles

Collier.

The acquisition represents a strategic pivot toward fresh,

original fantasy intellectual property following Disney's ( DIS ) mixed

results from live-action remakes of classic animated films.

While "Lilo & Stitch" proved successful this year, "Snow White"

disappointed at the box office.

"Our ambition is to build 'Glimouria' and 'Impossible

Creatures' into a spectacular series of films, so that we can

entertain and inspire family audiences across the world,"

Rundell said in a statement.

Disney ( DIS ) also secured the rights to be the first to review and

potentially make movies or shows based on Rundell's current and

upcoming literary properties, from her production company,

Impossible Films.

"When I read 'Impossible Creatures', I knew it belonged here

at Disney ( DIS )," Disney ( DIS ) CEO Bob Iger said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Chubb Q4 Core Earnings Fall, Net Premiums Written Rises
Chubb Q4 Core Earnings Fall, Net Premiums Written Rises
Jan 28, 2025
04:41 PM EST, 01/28/2025 (MT Newswires) -- Chubb ( CB ) late Tuesday reported Q4 core diluted earnings of $6.02 per share compared with $8.30 a year earlier. Analysts polled by Factset expected $5.44. Net premiums written by the insurer for the quarter ended Dec. 31 was $12.60 billion compared with $11.60 billion a year ago. Analysts were looking for...
Weave Communications Insider Sold Shares Worth $328,952, According to a Recent SEC Filing
Weave Communications Insider Sold Shares Worth $328,952, According to a Recent SEC Filing
Jan 28, 2025
04:37 PM EST, 01/28/2025 (MT Newswires) -- Branden Neish, Chief Product & Technology Officer, on January 27, 2025, sold 20,741 shares in Weave Communications ( WEAV ) for $328,952. Following the Form 4 filing with the SEC, Neish has control over a total of 491,381 shares of the company, with 491,381 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1609151/000160915125000005/xslF345X05/wk-form4_1738099658.xml ...
Stride Fiscal Q2 Earnings, Revenue Increase; Fiscal 2025 Revenue Guidance Raised
Stride Fiscal Q2 Earnings, Revenue Increase; Fiscal 2025 Revenue Guidance Raised
Jan 28, 2025
04:41 PM EST, 01/28/2025 (MT Newswires) -- Stride (LRN) reported a fiscal Q2 net income late Tuesday of $2.03 per diluted share, up from $1.54 a year ago. Analysts polled by FactSet expected $1.95. Revenue for the quarter ended Dec. 31 was $587.2 million, up from $504.9 million a year earlier. Four analysts surveyed by FactSet expected $569.7 million. The...
Nurix Therapeutics Fiscal Q4 Net Loss Narrows, Revenue Falls
Nurix Therapeutics Fiscal Q4 Net Loss Narrows, Revenue Falls
Jan 28, 2025
04:42 PM EST, 01/28/2025 (MT Newswires) -- Nurix Therapeutics ( NRIX ) reported a fiscal Q4 net loss Tuesday of $0.75 per diluted share, narrowing from the loss of $0.77 a year earlier. Analysts polled by FactSet expected a loss of $0.69. Revenue in the three months ended Nov. 30 fell to $13.3 million from $15.2 million a year earlier....
Copyright 2023-2026 - www.financetom.com All Rights Reserved